Hagiwara, Akifumi
Tatekawa, Hiroyuki
Yao, Jingwen
Raymond, Catalina
Everson, Richard
Patel, Kunal
Mareninov, Sergey
Yong, William H.
Salamon, Noriko
Pope, Whitney B.
Nghiemphu, Phioanh L.
Liau, Linda M.
Cloughesy, Timothy F.
Ellingson, Benjamin M.
Funding for this research was provided by:
UCLA SPORE in Brain Cancer (NIH/NCI 1P50CA211015-01A1)
American Cancer Society (RSG-15-003-01-CCE)
University of California Research Coordinating Committee
UCLA Jonsson Comprehensive Cancer Center Seed Grant
National Institutes of Health (NIH/NCI 1R21CA223757-01)
Article History
Received: 13 August 2021
Accepted: 10 December 2021
First Online: 20 January 2022
Competing interests
: BME is on advisory board of Hoffman La-Roche, Siemens, Nativis, Medicenna, MedQIA, Bristol Meyers Squibb, Imaging Endpoints, and Agios. BME is a paid consultant of Nativis, MedQIA, Siemens, Hoffman La-Roche, Imaging Endpoints, Medicenna, and Agios. BME has grant funding by Hoffman La-Roche, Siemens, Agios, and Janssen. BME holds a patent on this technology (US Patent #15/577,664; International PCT/US2016/034886). The other authors declare no competing interests.